1. Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case
- Author
-
Liu F, Qi F, Zhang X, Cao M, and Peng S
- Subjects
primary cutnaeous diffuse large b-cell lymphoma ,leg type，rituximab plus cyclophosphamide ,doxorubicin ,vincristine ,and prednisone (r-chop) ，remission ,Dermatology ,RL1-803 - Abstract
Fang Liu, Fei Qi, Xiuying Zhang, Mei Cao, Shiguang Peng Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Fang Liu, Email roseliufang@qq.comAbstract: Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LTs) is a rare and the most aggressive type of the cutaneous B-cell lymphoma with poor prognosis and low therapeutic response. It mostly affects elderly women, with a 5-year survival rate of 50% if not efficiently treated. We present a 28-year-old male patient with indolent PCDLBCL-LT who reached nearly 100% clearance after six rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy sessions.Keywords: primary cutaneous diffuse large B-cell lymphoma, leg type, rituximab plus cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP), remission
- Published
- 2022